Lauren Miller
Adolescent Medicine · Bel Air, MDNPI 1932307535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 52 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$183
- Merck$157
- Tris Pharma Inc$149
- Ironshore Pharmaceuticals Inc.$135
- Cranial Technologies, Inc$50
- Supernus Pharmaceuticals, Inc.$36
- plus $349 from 15 others
What the payments were for
- Food & beverage$1,058100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $183 |
| Merck | 8 | $157 |
| Tris Pharma Inc | 9 | $149 |
| Ironshore Pharmaceuticals Inc. | 6 | $135 |
| Cranial Technologies, Inc | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 1 | $33 |
| Sanofi Pasteur Inc. | 1 | $33 |
| Neos Therapeutics, LP | 2 | $32 |
| Shire North American Group Inc | 2 | $31 |
| Collegium Pharmaceutical, Inc. | 1 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| AbbVie | 1 | $23 |
| Adlon Therapeutics L.p. | 2 | $23 |
| LNHC, Inc | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| GSK | 1 | $16 |
| Mission Pharmacal Company | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
How this compares
$1,058 in reported general payments places this provider in the 85th percentile of 92 adolescent medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $60 |
| Tizanidine Hcl | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other adolescent medicine in Bel Air
- Jennifer CoxBel Air$2K
- M LomonicoBel Air$936
- Thomas SeymourBel Air$375
- Errol FieldsBaltimore$25K
- Ligia PeraltaSilver Spring$23K
- Netanel SchwobBaltimore$5K
- Robert WeissHagerstown$3K
- Leon WeaverHagerstown$2K
- Nina KashtelyanBaltimore$2K
- Ngozi AgwunaEllicott City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.